ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $43,044,000 | +31.8% | 250,118 | -3.9% | 0.01% | +33.3% |
| Q2 2021 | $32,653,000 | -7.4% | 260,203 | +0.1% | 0.01% | -14.3% |
| Q1 2021 | $35,264,000 | +7.8% | 260,033 | +1.7% | 0.01% | +16.7% |
| Q4 2020 | $32,704,000 | +13.5% | 255,626 | -0.2% | 0.01% | 0.0% |
| Q3 2020 | $28,811,000 | +25.8% | 256,037 | +6.5% | 0.01% | +20.0% |
| Q2 2020 | $22,896,000 | -56.8% | 240,318 | -59.2% | 0.01% | -66.7% |
| Q1 2020 | $52,940,000 | +70.4% | 589,072 | +0.5% | 0.02% | +114.3% |
| Q4 2019 | $31,061,000 | +40.4% | 585,854 | +4.6% | 0.01% | +40.0% |
| Q3 2019 | $22,122,000 | +1.8% | 559,912 | +5.8% | 0.01% | 0.0% |
| Q2 2019 | $21,731,000 | -10.2% | 528,982 | +1.9% | 0.01% | -16.7% |
| Q1 2019 | $24,186,000 | +20.6% | 519,346 | +12.8% | 0.01% | 0.0% |
| Q4 2018 | $20,061,000 | -24.6% | 460,617 | -0.9% | 0.01% | -14.3% |
| Q3 2018 | $26,595,000 | +21.0% | 464,680 | +2.6% | 0.01% | +16.7% |
| Q2 2018 | $21,982,000 | +28.5% | 453,058 | +3.6% | 0.01% | +50.0% |
| Q1 2018 | $17,103,000 | -7.8% | 437,397 | +0.1% | 0.00% | -20.0% |
| Q4 2017 | $18,547,000 | +30.5% | 437,026 | +14.7% | 0.01% | +25.0% |
| Q3 2017 | $14,215,000 | +22.7% | 380,917 | -0.1% | 0.00% | +33.3% |
| Q2 2017 | $11,589,000 | +29.7% | 381,370 | +13.0% | 0.00% | 0.0% |
| Q1 2017 | $8,933,000 | +5.5% | 337,479 | +1.7% | 0.00% | 0.0% |
| Q4 2016 | $8,467,000 | -25.4% | 331,763 | +5.7% | 0.00% | -25.0% |
| Q3 2016 | $11,356,000 | +6.1% | 313,796 | -0.4% | 0.00% | +33.3% |
| Q2 2016 | $10,704,000 | +40.7% | 314,990 | +9.3% | 0.00% | 0.0% |
| Q1 2016 | $7,606,000 | -38.2% | 288,289 | +14.2% | 0.00% | -25.0% |
| Q4 2015 | $12,314,000 | +105.3% | 252,526 | +4.8% | 0.00% | +100.0% |
| Q3 2015 | $5,999,000 | +8.6% | 240,919 | +38.0% | 0.00% | 0.0% |
| Q2 2015 | $5,524,000 | -11.5% | 174,614 | +6.5% | 0.00% | 0.0% |
| Q1 2015 | $6,240,000 | -2.8% | 163,958 | -0.5% | 0.00% | 0.0% |
| Q4 2014 | $6,420,000 | +27.4% | 164,793 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $5,039,000 | +46.9% | 166,660 | +65.1% | 0.00% | +100.0% |
| Q2 2014 | $3,430,000 | +14.8% | 100,961 | +16.6% | 0.00% | 0.0% |
| Q1 2014 | $2,989,000 | -13.6% | 86,615 | -0.8% | 0.00% | 0.0% |
| Q4 2013 | $3,458,000 | – | 87,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |